Medical Research at James River OB/Gyn
James River OB/Gyn is proud to partner with Clinical Research Partners, LLC.
This partnership allows the providers here at James River OB/Gyn to offer inclusion into a number of cutting-edge medical research studies. For patients, being involved in research offers the ability to help test some of the more effective new treatments available for certain medical conditions they may be suffering from. In turn, their involvement in these studies will ultimately offer help to many women throughout the world who will benefit from these medications or treatments once they are fully approved by the FDA. Finally, participation is oftentimes reimbursed with cash incentives for participating!
Here is a current list of available studies. Please talk to your provider or contact Prechus Talor via email if you’re interested in being involved in any of the following studies.
- Abbvie Endometriosis Study (969)
- Phase 3 Drug study testing combination of Elagolix (Orilissa) in combination with Oral Contraceptives in women with moderate to severe pain from endometriosis
- Abbvie Endometriosis Study (702)
- Phase 3 Drug study testing combination of Elagolix (Orilissa) in combination with Estradiol Norethindrone (hormone replacement) in women with moderate to severe pain from endometriosis.
- Glaxo Smith Kline UTI Study (212390)
- Phase 3 Drug Study looking at Geopticidin vs. Nitrofurantoin for treating acute urinary tract infection.
- Pfizer RSV Vaccine (3671008)
- Phase 3 Study comparing vaccine for Respiratory Syncytial Virus vs. Placebo in pregnant mothers.
- Testing infant immunity to RSV after birth.
- Myovant Serene OCP Study
- Phase 3 Study to test the effectiveness of a new medical treatment for endometriosis at preventing pregnancy.
- Year-long birth control study.
Please don’t hesitate to contact us if you’re interested in participating in any of the above research studies. You will help others and make a little extra spending money in the process. Note that James River Ob/Gyn only participates in Phase 2 and Phase 3 studies. These are studies nearing approval by the FDA.Clinical Research Trial Phase Information